Intranasal administration of broad-spectrum macrocyclic peptide inhibitor protects against SARS-CoV-2 Omicron variants.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Intranasal administration of broad-spectrum macrocyclic peptide inhibitor protects against SARS-CoV-2 Omicron variants.
- Published In:
- Nature communications, 17(1), 1753 (2026)
- Authors:
- Wang, Min(4), Yang, Jinyue, Tan, Yahong, Yuan, Shuofeng, Shi, Guoli, Peng, Qi, Li, Yongqi, Poon, Vincent Kwok-Man, Chan, Chris Chung-Sing, Xiao, Na, Zhang, Anna Jinxia, Xie, Yubin, Li, Junhua, Luo, Hao, Fu, Yaning, Chen, Yong, Compton, Alex A, Zhang, Youming, Yang, Yang, Gao, George Fu, Hou, Hongwei, Chan, Jasper Fuk-Woo, Yin, Yizhen, Shi, Yi
- Database ID:
- RPEP-16363
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-16363APA
Wang, Min; Yang, Jinyue; Tan, Yahong; Yuan, Shuofeng; Shi, Guoli; Peng, Qi; Li, Yongqi; Poon, Vincent Kwok-Man; Chan, Chris Chung-Sing; Xiao, Na; Zhang, Anna Jinxia; Xie, Yubin; Li, Junhua; Luo, Hao; Fu, Yaning; Chen, Yong; Compton, Alex A; Zhang, Youming; Yang, Yang; Gao, George Fu; Hou, Hongwei; Chan, Jasper Fuk-Woo; Yin, Yizhen; Shi, Yi. (2026). Intranasal administration of broad-spectrum macrocyclic peptide inhibitor protects against SARS-CoV-2 Omicron variants.. Nature communications, 17(1), 1753. https://doi.org/10.1038/s41467-026-68462-9
MLA
Wang, Min, et al. "Intranasal administration of broad-spectrum macrocyclic peptide inhibitor protects against SARS-CoV-2 Omicron variants.." Nature communications, 2026. https://doi.org/10.1038/s41467-026-68462-9
RethinkPeptides
RethinkPeptides Research Database. "Intranasal administration of broad-spectrum macrocyclic pept..." RPEP-16363. Retrieved from https://rethinkpeptides.com/research/wang-2026-intranasal-administration-of-broadspectrum
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.